178 related articles for article (PubMed ID: 35821038)
1. Stochastic model of ERK-mediated progesterone receptor translocation, clustering and transcriptional activity.
Marquez-Lago TT; Steinberg S
Sci Rep; 2022 Jul; 12(1):11791. PubMed ID: 35821038
[TBL] [Abstract][Full Text] [Related]
2. CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin.
Vallejo G; La Greca AD; Tarifa-Reischle IC; Mestre-Citrinovitz AC; Ballaré C; Beato M; Saragüeta P
PLoS One; 2014; 9(5):e97311. PubMed ID: 24859236
[TBL] [Abstract][Full Text] [Related]
3. hCG activates Epac-Erk1/2 signaling regulating Progesterone Receptor expression and function in human endometrial stromal cells.
Tapia-Pizarro A; Archiles S; Argandoña F; Valencia C; Zavaleta K; Cecilia Johnson M; González-Ramos R; Devoto L
Mol Hum Reprod; 2017 Jun; 23(6):393-405. PubMed ID: 28333280
[TBL] [Abstract][Full Text] [Related]
4. Progesterone signaling in breast and endometrium.
Ballaré C; Vallejo G; Vicent GP; Saragüeta P; Beato M
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):2-10. PubMed ID: 17070033
[TBL] [Abstract][Full Text] [Related]
5. Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.
Faivre EJ; Daniel AR; Hillard CJ; Lange CA
Mol Endocrinol; 2008 Apr; 22(4):823-37. PubMed ID: 18202149
[TBL] [Abstract][Full Text] [Related]
6. Regulation of progesterone receptor messenger ribonucleic acid by progestin in human endometrial stromal cells.
Tseng L; Zhu HH
Biol Reprod; 1997 Dec; 57(6):1360-6. PubMed ID: 9408241
[TBL] [Abstract][Full Text] [Related]
7. Chromatin remodeling and control of cell proliferation by progestins via cross talk of progesterone receptor with the estrogen receptors and kinase signaling pathways.
Vicent GP; Ballaré C; Zaurin R; Saragüeta P; Beato M
Ann N Y Acad Sci; 2006 Nov; 1089():59-72. PubMed ID: 17261755
[TBL] [Abstract][Full Text] [Related]
8. Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth.
Daniel AR; Qiu M; Faivre EJ; Ostrander JH; Skildum A; Lange CA
Steroids; 2007 Feb; 72(2):188-201. PubMed ID: 17173941
[TBL] [Abstract][Full Text] [Related]
9. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.
Dai D; Kumar NS; Wolf DM; Leslie KK
Am J Obstet Gynecol; 2001 Apr; 184(5):790-7. PubMed ID: 11303185
[TBL] [Abstract][Full Text] [Related]
10. Progestin activation of nongenomic pathways via cross talk of progesterone receptor with estrogen receptor beta induces proliferation of endometrial stromal cells.
Vallejo G; Ballaré C; Barañao JL; Beato M; Saragüeta P
Mol Endocrinol; 2005 Dec; 19(12):3023-37. PubMed ID: 16020483
[TBL] [Abstract][Full Text] [Related]
11. Role of nuclear progesterone receptor isoforms in uterine pathophysiology.
Patel B; Elguero S; Thakore S; Dahoud W; Bedaiwy M; Mesiano S
Hum Reprod Update; 2015; 21(2):155-73. PubMed ID: 25406186
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294.
Shen T; Horwitz KB; Lange CA
Mol Cell Biol; 2001 Sep; 21(18):6122-31. PubMed ID: 11509655
[TBL] [Abstract][Full Text] [Related]
13. Progesterone receptor action: translating studies in breast cancer models to clinical insights.
Lange CA; Sartorius CA; Abdel-Hafiz H; Spillman MA; Horwitz KB; Jacobsen BM
Adv Exp Med Biol; 2008; 630():94-111. PubMed ID: 18637487
[TBL] [Abstract][Full Text] [Related]
14. Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line.
Beranič N; Lanišnik Rižner T
Chem Biol Interact; 2013 Feb; 202(1-3):218-25. PubMed ID: 23183084
[TBL] [Abstract][Full Text] [Related]
15. Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming.
Diep CH; Knutson TP; Lange CA
Mol Cancer Res; 2016 Feb; 14(2):141-62. PubMed ID: 26577046
[TBL] [Abstract][Full Text] [Related]
16. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.
Salazar M; Lerma-Ortiz A; Hooks GM; Ashley AK; Ashley RL
Gene; 2016 Oct; 591(1):6-13. PubMed ID: 27349565
[TBL] [Abstract][Full Text] [Related]
17. An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity.
Wei LL; Hawkins P; Baker C; Norris B; Sheridan PL; Quinn PG
Mol Endocrinol; 1996 Nov; 10(11):1379-87. PubMed ID: 8923464
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of long non-coding HOTAIR enhances the sensitivity to progesterone in endometrial cancer by epigenetic regulation of progesterone receptor isoform B.
Chi S; Liu Y; Zhou X; Feng D; Xiao X; Li W; Zhao Y; Wang H
Cancer Chemother Pharmacol; 2019 Feb; 83(2):277-287. PubMed ID: 30443761
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin.
Pant A; Lee II; Lu Z; Rueda BR; Schink J; Kim JJ
PLoS One; 2012; 7(7):e41593. PubMed ID: 22911820
[TBL] [Abstract][Full Text] [Related]
20. Complex agonist-like properties of ICI 182,780 (Faslodex) in human breast cancer cells that predominantly express progesterone receptor-B: implications for treatment resistance.
Wu J; Liang Y; Nawaz Z; Hyder SM
Int J Oncol; 2005 Dec; 27(6):1647-59. PubMed ID: 16273221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
